Beyond Air’s delivery system incorporates the proprietary and patented LungFit™ platform, which generates Nitric Oxide gas from room air. LungFit™ is designated a medical device at the Food and Drug Administration (FDA).
LungFit™ can generate NO on demand for delivery to the lungs at concentrations ranging from 1 part per million (ppm) to 400 ppm. With this technology, Beyond Air can target all conditions requiring NO at any concentration, regardless of the need for intermittent or continuous dosing.
The elimination of large, high-pressure cylinders for NO is a significant advantage in the hospital setting and potentially allows for use in the home setting.
In the hospital setting, there would be no inventory or storage requirements, added equipment, purging procedures or external oxygen necessary.
LungFit BRO™ weighs approximately 6lbs for high concentration delivery and may scale down to lower weights for lower concentrations in the home setting.
Beyond Air projects that the use of Nitric Oxide in the hospital setting would expand with its technology as currently many hospitals can’t use Nitric Oxide due to capital investment and associated costs, but now will have the ability with our system.